Trials / Completed
CompletedNCT06785714
Colorectal Cancer Screening in Xinxiang City
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25,000 (actual)
- Sponsor
- The First Affiliated Hospital of Xinxiang Medical College · Academic / Other
- Sex
- All
- Age
- 45 Years – 74 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to evaluate the sensitivity of the fecal protein dual-index test reagent for the detection of colorectal cancer (CRC).
Detailed description
The project uses fecal hemoglobin and transferrin dual-index combined with reagents that can be self-tested at home (referred to as fecal protein dual-index detection reagents), combined with colorectal cancer risk factor questionnaires, to carry out colorectal cancer screening in people of specific ages in the city, aiming to achieve early screening, early diagnosis and early treatment, and evaluate the effect of fecal protein dual-index detection reagents in early screening of colorectal cancer, so as to provide a scientific basis for optimizing the national screening program.
Conditions
Timeline
- Start date
- 2024-09-01
- Primary completion
- 2025-01-15
- Completion
- 2025-01-15
- First posted
- 2025-01-21
- Last updated
- 2025-01-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06785714. Inclusion in this directory is not an endorsement.